SCOPOLAMINE
| Brand name | SCOPOLAMINE |
|---|---|
| Active ingredient | SCOPOLAMINE |
| Strength | 1MG/72HR |
| Dosage form | SYSTEM |
| Route | TRANSDERMAL |
| Modality | Small molecule |
| FDA approval | June 2025 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.